Marleen Van den Horst

Practice Areas

* IP & technology

* Life sciences, Pharma & regulatory

* Patents and technology

* Healthcare

Career

IP & Technology partner Marleen van den Horst (J.D.) has over 25 years’ experience in multi-jurisdictional patent litigation, since 2023 including cases before the UPC. She successfully represents clients in patent disputes in all fields of technology. She is internationally renowned for her patent, regulatory and product liability work in life sciences. Marleen conducts patent/SPC litigation and advises on blockbuster molecules like escitalopram, glatiramer acetate, rivastigmine, zoledronate, fingolimod, eculizumab and on CRISPRCas9 technology. In the field of high tech/telecoms Marleen advises on European litigation strategy for enforcing SEP patents and FRAND-related issues. She is a frequent speaker at international conferences.

Professional Memberships

* Board member of the NeoKidney Foundation for the realisation of a wearable artificial kidney.

* Member of several professional organisations and trade associations, such as EPLAW,

AIPPI, LES, VF&R and VIEPA.